Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Drospirenone/Ethinyl Estradiol · Yaz

Small molecule · Modulator of estrogen receptor alpha (ESR1) and progesterone receptor (PGR) · developed by Bayer Healthcare Pharmaceuticals

Approved FDA
1 Registered trials

What is Drospirenone/Ethinyl Estradiol?

Drospirenone/ethinyl estradiol is a combined oral contraceptive pairing the progestin drospirenone with the estrogen ethinyl estradiol. The combination suppresses the hypothalamic-pituitary system, inhibiting FSH and LH release and ovulation, and thickens cervical mucus. It is used to prevent pregnancy and to treat premenstrual dysphoric disorder and moderate acne in women choosing it for contraception.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as
Yaz
Drug type
Small molecule
Targets
estrogen receptor alpha (ESR1), progesterone receptor (PGR)
Mechanism
Modulator of estrogen receptor alpha (ESR1) and progesterone receptor (PGR)
Pathways
hypothalamic-pituitary-gonadal axis suppression, gonadotropin (FSH and LH) release inhibition, ovulation inhibition, cervical mucus thickening, endometrial alteration
Therapy area
Dermatology, Psychiatry, Women's health
Developer
Bayer Healthcare Pharmaceuticals Inc.
In trials of
NAMS
FDA status
Approved as Yaz, NDA021676 · FDA label

✅ FDA-approved uses

From the indications section of the FDA label (version of May 29, 2025). Read the full label for the exact wording, limitations and safety information.

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT06250205 Phase 1 Healthy Volunteers Completed NAMS

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Healthy Volunteers

Other drugs acting on ESR1 / PGR

Sources

Updated Oct 25, 2026.

Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.